Kanwar JR, Jagat R Kanwar, Jagat R Kanwar, Jagat Rakesh, Kanwar R. Jagat, Rakesh Jagat
Kanwar JR, Jagat R Kanwar, Jagat R Kanwar, Jagat Rakesh, Kanwar R. Jagat, Rakesh Jagat
Deakin University, University of Auckland
Verified email at deakin.edu.au
TitleCited byYear
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives
D Chen, M Frezza, S Schmitt, J Kanwar, Q P Dou
Current cancer drug targets 11 (3), 239-253, 2011
Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
X Sun, JR Kanwar, E Leung, K Lehnert, D Wang, GW Krissansen
Gene therapy 8 (8), 638-645, 2001
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy
JR Kanwar, WP Shen, RK Kanwar, RW Berg, GW Krissansen
Journal of the National Cancer Institute 93 (20), 1541-1552, 2001
Recent advances on the roles of NO in cancer and chronic inflammatory disorders
JR Kanwar, RK Kanwar, H Burrow, S Baratchi
Current medicinal chemistry 16 (19), 2373-2394, 2009
Recent advances on tea polyphenols
J Kanwar, M Taskeen, I Mohammad, C Huo, TH Chan, QP Dou
Frontiers in bioscience (Elite edition) 4, 111, 2012
Mouse B7-H3 induces antitumor immunity
X Sun, M Vale, E Leung, JR Kanwar, R Gupta, GW Krissansen
Gene therapy 10 (20), 1728-1734, 2003
Treat cancers by targeting survivin: just a dream or future reality?
MS Coumar, FY Tsai, JR Kanwar, S Sarvagalla, CHA Cheung
Cancer treatment reviews 39 (7), 802-811, 2013
Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6
SL Mo, YH Liu, W Duan, MQ Wei, JR Kanwar, SF Zhou
Current drug metabolism 10 (7), 730-753, 2009
Chimeric aptamers in cancer cell-targeted drug delivery
JR Kanwar, K Roy, RK Kanwar
Critical reviews in biochemistry and molecular biology 46 (6), 459-477, 2011
Targeting survivin in cancer: the cell-signalling perspective
JR Kanwar, SK Kamalapuram, RK Kanwar
Drug discovery today 16 (11-12), 485-494, 2011
Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis
JR Kanwar, RK Kanwar, GW Krissansen
Brain 127 (6), 1313-1331, 2004
Recent advances in anti-survivin treatments for cancer
RK Kanwar, CH A Cheung, JY Chang, JR Kanwar
Current medicinal chemistry 17 (15), 1509-1515, 2010
β7 integrins contribute to demyelinating disease of the central nervous system
JR Kanwar, JEB Harrison, D Wang, E Leung, W Mueller, N Wagner, ...
Journal of neuroimmunology 103 (2), 146-152, 2000
Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice
RK Kanwar, JR Kanwar, D Wang, DJ Ormrod, GW Krissansen
Arteriosclerosis, thrombosis, and vascular biology 21 (12), 1991-1997, 2001
Microfluidic devices for cell cultivation and proliferation
M Tehranirokh, AZ Kouzani, PS Francis, JR Kanwar
Biomicrofluidics 7 (5), 051502, 2013
Survivin signaling in clinical oncology: a multifaceted dragon
JR Kanwar, SK Kamalapuram, RK Kanwar
Medicinal research reviews 33 (4), 765-789, 2013
Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system
S Bivalkar-Mehla, J Vakharia, R Mehla, M Abreha, JR Kanwar, A Tikoo, ...
Virus research 155 (1), 1-9, 2011
Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy
M Puri, I Kaur, RK Kanwar, RC Gupta, A Chauhan, JR Kanwar
Current molecular medicine 9 (9), 1080-1094, 2009
‘Iron‐saturated’lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy
JR Kanwar, KP Palmano, X Sun, RK Kanwar, R Gupta, N Haggarty, ...
Immunology and cell biology 86 (3), 277-288, 2008
Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats
G Tan, S Pan, J Li, X Dong, K Kang, M Zhao, X Jiang, JR Kanwar, H Qiao, ...
PloS one 6 (10), 2011
The system can't perform the operation now. Try again later.
Articles 1–20